Search Results - "I. A. Vilyum"

Pharmacoeconomic analysis of atezolizumab plus nab-paclitaxel in the treatment of the advanced or metastatic triple-negative breast cancer by Kolbin, A S, Vilyum, I A, Proskurin, M A, Balikina, Yu E, Pavlysh, A V

“…Objective. To determine the pharmacoeconomical feasibility of using a combination of atezolizumab + nab-paclitaxel in the 1st line of therapy for locally…”
Get full text

Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia by Vilyum, I. A., Andreev, B. V., Proskurin, M. A., Balykina, Yu. E.

“…The aim: to provide a comprehensive pharmacoeconomic evaluation of the maintenance therapy with antipsychotics in outpatients diagnosed with schizophrenia…”
Get full text

Pharmacoeconomic analysis of using mirabegron to treat overactive bladder in the setting of the Russian Federation health care by Kolbin, A S, Vilyum, I A, Proskurin, M A, Balykina, Yu E

“…The present paper presents, for the first time in Russia, a comparative pharmacoeconomic analysis of using mirabegron (Betmiga) to treat overactive bladder…”
Get more information

MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 by Kolbin, A. S., Prasolov, A. V., Maksimkina, E. A., Balykina, Yu. E., Golant, Z. M., Polushin, Yu. S., Kurylev, A. A., Vilyum, I. A.

“…Background: In 2014 we firstly analyzed the formalized system (points and expert opinions) of drug inclusion and exclusion into the reimbursement lists in…”
Get full text

Social-economic burden of Pompe disease with late onset in the Russian Federation by A. S. Kolbin, I. A. Vilyum, Yu. E. Balikina, M. A. Proskurin, O. I. Karpov

“…Pompe disease (PD) — a rare disease with progressive muscles weakness, cardiac and pulmonary insufficiency and others vital life-threatening symptoms without…”
Get full text

Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia by I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina

“…The aim: to provide a comprehensive pharmacoeconomic evaluation of the antipsychotic maintenance therapy in outpatients diagnosed with schizophrenia.Materials…”
Get full text

Socio-economic burden of chronic migraine in Russia by A. A. Kolbin, M. V. Naprienko, A. R. Artemenko, I. A. Vilyum, N. V. Latysheva, M. A. Proskurin, Yu. Ye. Balykina

“…Introduction. Results of both clinical and epidemiological studies demonstrate a high frequency of work incapacity associated with headache, reduced…”
Get full text

Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital by A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina

“…for the first time in the Russian conditions the pharmacoeconomic analysis examined the application dalteparin in comparison with other low-molecular-weight…”
Get full text

BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD by Kolbin, A.S., Vilyum, I.A., Proskurin, M.A., Balykina, Yu.E.

“…We have performed the first-ever Budget Impact Analysis (BIA) in a Russian context of bendamustine in the first line of therapy of a multiple myeloma for…”
Get full text